from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2391/sirA

LFCtreatmentdescriptionclass of inhibitor

0.853

Amikacinug/mL Amikacintranslation

0.105

Cap5-10ug/mL Capreomycintranslation

0.576

Rox10-50 ug/mL Roxithromycintranslation

1.027

SM2-5 ug/mL Streptomycintranslation

1.696

Tet5-10 ug/mL Tetracyclinetranslation

0.402

Rif0.2-5ug/mL Rifampicintranscription

0.608

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.049

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.678

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.885

CPZ10-50 ug/mL Chlorpromazinerespiration

0.482

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.299

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.636

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.352

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.912

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.530

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.473

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.145

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.821

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.393

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.656

KCN5-20 ug/mL Potassium cyaniderespiration

-1.625

NaN30.2-2 mM Sodium aziderespiration

-0.382

Nigericin50 uM Nigericinrespiration

-0.842

TRC10-150 ug/mL Triclosanrespiration

0.009

TRZ10-25 ug/mL Thioridazinerespiration

-0.077

Valinomycin0.5-10 uM Valinomycinrespiration

1.107

ZnSO42 mM ZnSO4respiration

2.140

menadione6-10 ug/mL Menadionerespiration

0.318

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.284

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.432

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.890

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.806

NRP_1Non-replicating persistence stage 1dosRassociated

0.296

Amp0.2mg/mL AmpicillincellWall

0.243

Cephalexin20-100 ug/mL CephalexincellWall

-1.159

Cerulenin0.32-5 ug/mL CerulenincellWall

0.194

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.050

EMB10-20 ug/mL EthambutolcellWall

0.083

Eta12-40 ug/mL EthionamidecellWall

0.623

INH0.2-0.4 ug/mL IsoniazidcellWall

0.353

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.156

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.089

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.200

BZA0.12 mg/mL BenzamidearomaticAmides

-0.476

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.138

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.882

H2O24 mM hydrogen peroxideDNAdamaging

0.261

Levo10 ug/mL LevofloxacinDNAdamaging

-0.511

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.310

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.480

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.026

UVUV-irradiationDNAdamaging

2.004

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.073

Antimycin12.5-50 ug/mL Antimycin A?

0.201

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.801

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.564

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.242

PA8240.2-2 ug/mL PA-824?

-1.024

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.500

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.402

Verapamil50 uM Verapamil?

0.512

mercaptoethanol2 mM 2-Mercaptoethanol?

0.228

methoxatin10-20 ug/mL Methoxatin?